• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Letter by Bonassi on Article, "Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

作者信息

Katsanos Konstantinos, Spiliopoulos Stavros, Kitrou Panagiotis, Krokidis Miltiadis, Karnabatidis Dimitrios

机构信息

1 Patras University Hospital Rion Greece.

2 Attikon University Hospital Athens Greece.

出版信息

J Am Heart Assoc. 2019 May 21;8(10):e012172. doi: 10.1161/JAHA.119.012172.

DOI:10.1161/JAHA.119.012172
PMID:31094263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6585331/
Abstract
摘要

相似文献

1
Response to Letter by Bonassi on Article, "Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".对博纳西就文章《紫杉醇涂层球囊和支架应用于下肢股腘动脉后的死亡风险：一项随机对照试验的系统评价和荟萃分析》所写信件的回复
J Am Heart Assoc. 2019 May 21;8(10):e012172. doi: 10.1161/JAHA.119.012172.
2
Letter by Bonassi Regarding Article, "Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".博纳西就“紫杉醇涂层球囊和支架应用于下肢股腘动脉后的死亡风险：随机对照试验的系统评价和荟萃分析”一文所写的信
J Am Heart Assoc. 2019 May 21;8(10):e012315. doi: 10.1161/JAHA.119.012315.
3
Rigorous focus on paclitaxel-related mortality in femoropopliteal artery disease.严格关注股浅动脉疾病中与紫杉醇相关的死亡率。
J Vasc Surg. 2020 Jan;71(1):216-219. doi: 10.1016/j.jvs.2019.10.010.
4
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.紫杉醇涂层球囊血管成形术治疗股腘外周动脉疾病的安全性。
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2515-2524. doi: 10.1016/j.jcin.2019.08.025. Epub 2019 Sep 28.
5
Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.用于股腘动脉疾病的紫杉醇涂层球囊
Curr Cardiol Rep. 2017 Feb;19(2):10. doi: 10.1007/s11886-017-0823-4.
6
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive.股腘动脉紫杉醇涂层器械的死亡风险仍无定论。
Cardiovasc Interv Ther. 2019 Apr;34(2):194-195. doi: 10.1007/s12928-019-00573-1. Epub 2019 Feb 8.
7
What Now for the Endovascular Community After the Paclitaxel Mortality Meta-Analysis: Can Sirolimus Replace Paclitaxel in the Peripheral Vasculature?紫杉醇死亡率荟萃分析后血管内治疗领域何去何从：西罗莫司能否在外周血管系统中取代紫杉醇？
J Endovasc Ther. 2020 Feb;27(1):153-156. doi: 10.1177/1526602819881156. Epub 2019 Oct 14.
8
Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison.紫杉醇涂层球囊或第一代裸镍钛合金支架用于股腘动脉血运重建：与未涂层球囊对比的随机试验荟萃分析及校正间接比较
Int J Cardiol. 2013 Oct 9;168(4):4002-9. doi: 10.1016/j.ijcard.2013.06.081. Epub 2013 Jul 23.
9
Novel Strategies to Reduce Femoropopliteal Restenosis: Low-Dose Paclitaxel-Coated Balloons and Paclitaxel-Coated Balloons Plus Stenting.减少股腘动脉再狭窄的新策略：低剂量紫杉醇涂层球囊及紫杉醇涂层球囊联合支架置入术
Circulation. 2017 Jun 6;135(23):2237-2240. doi: 10.1161/CIRCULATIONAHA.117.028308. Epub 2017 Apr 19.
10
Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.紫杉醇暴露与死亡率不相关：药物涂层球囊的独立患者水平荟萃分析。
J Am Coll Cardiol. 2019 May 28;73(20):2550-2563. doi: 10.1016/j.jacc.2019.01.013. Epub 2019 Jan 25.

引用本文的文献

1
Biodegradable Stents in the Treatment of Arterial Stenosis.可生物降解支架在动脉狭窄治疗中的应用
J Clin Med. 2025 Jan 16;14(2):532. doi: 10.3390/jcm14020532.
2
A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy.血管内介入术后新生内膜增生发展现状的综述以及对免疫治疗新前景的简要阐述。
Transl Clin Pharmacol. 2023 Dec;31(4):191-201. doi: 10.12793/tcp.2023.31.e18. Epub 2023 Nov 22.
3
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health Administration.紫杉醇涂层装置治疗下肢血运重建术后退伍军人的生存和死亡原因：来自退伍军人健康管理局的见解。
J Am Heart Assoc. 2021 Feb 16;10(4):e018149. doi: 10.1161/JAHA.120.018149. Epub 2021 Feb 6.

本文引用的文献

1
Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.紫杉醇涂层球囊和支架在下肢股腘动脉中的应用死亡风险：随机对照试验的系统评价和荟萃分析。
J Am Heart Assoc. 2018 Dec 18;7(24):e011245. doi: 10.1161/JAHA.118.011245.